A research collaboration between Australia and Israel has called a genetic variation that influences the severity of symptoms in Rett syndrome. The finding is published in the worldwide journal Neurology.
A molecule that promotes brain development could serve as a possible treatment for Rett syndrome, the most common form of autism in girls, according to researchers at MIT’s Picower Institute for Learning and Memory and the Whitehead Institute for Biomedical Research.
The international journal, Neurology, recently published that a research team, jointly run by Australia and Israel, has discovered a genetic mutation that considerably influences the severity of symptoms in Rett syndrome.